mice. This suggests a requirement of p53 loss for the skin cancer development. Genome scan localized a chromosomal locus showing frequent allelic losses near D12Mit2, which may harbor a tumor suppressor gene. In addition, 23 loci distributed on 13 chromosomes exhibited allelic losses at frequencies of more than 20%. The genome-wide occurrence of allelic losses suggests that genomic instability of the skin tumors may be implicated in radiation-induced carcinogenesis. The present study is the first to report a mouse model system useful for the analysis of radiation induction of skin cancer in man.
Ionizing radiation exposure is one of the most wellestablished risk factors for a number of human solid tumors and hematologic malignancies. However, it is still unknown how the initial radiation-induced damage contributes to the development of cancer occurring many years later. The p53 tumor suppressor gene is the most frequently mutated gene in a wide variety of human cancers and suppresses tumorigenesis through multiple mechanisms. [1] [2] [3] Mice deficient for p53 (p53-KO) develop tumors at a very young age and p53(KO/ +) heterozygotes are extremely susceptible to tumor development by radiation. [4] [5] [6] Although the p53-KO mice primarily develop lymphomas, they display strain-dependent differences in the tumor spectrum. In p53-KO mice of the C57BL/6 genetic background, the predominant tumor type is thymic lymphoma, whereas testicular teratomas are as common as lymphomas in 129/Sv strain. 7) Hence, these animals would provide a model system to study the mechanism by which radiation contributes to the development of tumors of different types.
One of the radiation-induced processes in carcinogenesis is presumed to be allelic loss or loss of heterozygosity (LOH). A region showing LOH at a high frequency in multiple tumor specimens has been interpreted as harboring a tumor suppressor gene.
1-3) Accordingly, we previously performed a genome-wide scan of LOH in radiationinduced thymic lymphomas of F 1 and N2 backcross mice between BALB/c and MSM strains carrying a p53-KO allele. Three loci showing frequent LOH were localized on chromosomes 11, 12 and 16. [8] [9] [10] [11] In addition to lymphomas, we found the development of skin tumors in p53(KO/ +) mice as well, though the incidence was low in BALB/c×MSM F 1 mice. Skin tumors have never previously been reported in various mouse strains with partial and/or complete deficiency of the p53 gene. [4] [5] [6] [7] In the present experiment we have extended the analysis to p53(KO/ +) F 1 mice of C3H/He×MSM, and localized the regions showing frequent LOH. Genomewide occurrence of allelic losses was noted, which may implicate genomic instability in the development of radiation-induced skin tumors. Epidemiological analysis of atomic bomb survivors indicated a clear dose-dependent induction of non-melanoma skin cancers, 12) and the lack of an appropriate model system has hampered the elucidation of the molecular mechanisms involved in radiation induction of skin tumors. The mouse model system of p53(KO/ +) F 1 mice between C3H/He and MSM is likely to offer a useful system for the analysis of this important cancer in man.
MATERIALS AND METHODS
Mice, irradiation and tumors MSM is an inbred strain derived from Japanese wild mice, Mus musculus molossinus, and the establishment of p53(KO/ +) MSM mice was described previously. 8) F 1 hybrid mice between BALB/c and p53(KO/ +) MSM were subjected to γ-ray irradiation, 2.5 Gy four times at weekly intervals, starting at the age of 4 weeks. F 1 hybrids between C3H/He and p53(KO/ +) MSM were irradiated with a single dose of 3 Gy once when mice were 4 weeks old. Skin tumors were diagnosed by inspection and palpation of the mice and were confirmed upon autopsy. Nineteen skin tumors were obtained from F 1 hybrids between BALB/c and p53(KO/ +) MSM, but four were excluded from the analysis because of severe contamination with normal tissues. Thirty-four skin tumors were obtained from irradiated F 1 mice between C3H/He and p53(KO/ +) MSM. Tumor specimens were HE-stained and examined under microscope. Polymerase chain reaction (PCR) analysis Genomic DNA was extracted from skin tumors and normal brain. PCR was carried out by the use of standard protocols and products were separated by electrophoresis on 8% polyacrylamide gel. Microsatellite markers used were as previously reported. 13) p53 genotyping was carried out by using a set of three primers, as described previously. 8) One primer (F1-53) was located in exon 1 of the p53 gene, a second primer (R1-53) in a region 5′ to exon 3, and the remaining one (F2-neo) in the neo gene inserted.
RESULTS
A total of 276 F 1 mice between BALB/c (C) and p53(KO/ +) MSM (M) and 164 F 1 mice between C3H/He (H) and p53(KO/ +) MSM were subjected to γ-irradiation. p53 genotyping of these CM and HM F 1 mice was performed with PCR using a set of three primers that detected the wild-type p53 and the inserted neo gene. 8) Among the 276 CM F 1 mice, 133 were heterozygous for p53 and so were 87 of the 164 HM F 1 mice. Table I A B Fig. 1 . Histology of skin tumors. Benign demarcated tumor of skin appendage origin showing cyst-like structures containing exfoliated keratinocytes and amorphous material and lined by squamous epithelium, with occasional transition to medullary and double-layered duct patterns. A, 10× magnification; B, 50×. a higher incidence of skin tumors (39.1%). Histological examination of the radiation-induced tumors provided an impression of trichofolliculoma, benign demarcated tumor of skin appendage origin (Fig. 1 ). This type of tumor has not been observed previously in p53(KO/ +) mice.
4-7)
Interestingly, no skin tumor developed in p53(+ / +) mice of either background. p53 genotyping of the skin tumors showed loss of the wild-type allele at a frequency of as high as 81.6% (40/49), suggesting p53 inactivation in almost all of the skin tumors. As for hepatomas, the incidence was much higher in the HM F 1 mice (21.3%) than in the CM mice (0.72%). However, the incidences in p53(+ / +) and p53(KO/ +) HM F 1 mice did not much differ.
A primary screen was made on 25 HM F 1 skin tumors for LOH at 52 microsatellite marker loci which were distributed throughout the autosomes. Fig. 2 shows an example of such analyses with the D12Mit2 probe and Table II summarizes the results. There were eight loci exhibiting LOH at frequencies higher than 30%, and the LOH frequencies for D11Mit62 and D12Mit2 loci were even higher than 50%. To further localize these regions, marker loci in the vicinities were typed for all 49 F 1 tumors. Fig. 3 shows the extent of allelic losses in the 34 HM F 1 tumors on chromosome 12. Loss of a whole chromosome was found in two tumors, whereas LOH in part of the chromosome was detected in 26 tumors. Therefore, the region between D12Mit2 and D12Mit190 underwent allelic loss at the highest frequency in these tumors. In addition, the loss of D12Mit2 was biased toward the MSM allele (P=0.018); the loss of the MSM allele accounted for 17 cases of the 20 losses and that of the C3H allele for three. As for the 15 CM F 1 tumors examined, only five showed allelic loss at D12Mit2, with BALB/c allele-loss in three and MSM allele-loss in two. Allelic loss at D11Mit62 had a preference for the C3H and BALB/c chromosome carrying the wild-type p53 allele. Loss of the C3H and BALB/c alleles was detected in 26 tumors and 6 such losses were noted for the MSM allele. Besides, 24 of the 26 tumors underwent loss of the wild-type p53 allele. The result suggested that the preference noted at D11Mit62 was caused by loss of the wildtype p53 allele on the same chromosome 11.
DISCUSSION
The present study describes the development of skin tumors by γ-ray irradiation of F 1 mice between C3H/He or BALB/c and MSM carrying a p53-deficient allele. Histological examination suggests that the tumors are of epithelial cell origin (Fig. 1) . Most of the tumors had lost the wild-type p53 allele and no tumor was induced in p53 + / + mice of the same genetic background (Table I) . These results strongly suggest a requirement of p53 loss for development of the tumors under the conditions employed in the present study. Interestingly, the incidence of skin tumors was higher in F 1 mice of the HM genetic background than in those of the CM background ( Table I) . The difference may reflect a modifier(s) that contributes to the tumor development in combinations with p53 deficiency. A modifier of testicular teratomas was previously reported for p53-deficient mice of the C57BL/6 and 129/Sv strains.
7)
Genome-wide analyses revealed that the D12Mit2 locus underwent allelic loss at a frequency of more than 50% and the loss appeared to have a preference for the MSM allele in HM F 1 mice. Therefore, this locus may harbor a tumor suppressor gene for skin tumor development and the MSM allele could be a functional gene while the C3H allele mutated. Database search did not provide any candidate gene within this chromosomal region. The D11Mit62 locus exhibited a high LOH frequency. However, most of the allelic losses were accompanied by the loss of the wild-type p53 allele on the same chromosome 11. Therefore, a tumor suppressor gene is less likely to reside in the region. In addition, there were many other loci exhibiting LOH at high frequencies, six showing more than 30% and five more than 20% (Table II) . This may suggest the existence of tumor suppressor genes in these regions. Alternatively, such genome-wide allelic losses may be secondary results of genomic instability associated with the development of skin tumors, although a high frequency of changes does not always reflect a high rate of genomic alterations. 14) Radiation is known to induce skin cancer in man. 12) However, no animal model system for γ-ray-induced skin carcinogenesis has been developed. Previous models develop skin cancers after repeated local β-irradiation of the backs of mice and rats. 15, 16) Heterozygous mice with a p53-deficient allele exhibit enhanced susceptibility to various cancers after irradiation 6, 17) and the present study has revealed that p53(KO/ +) F 1 mice between C3H/He and MSM strains were sensitive to radiation induction of skin tumors. The MSM strain is an inbred line derived from Japanese wild mice, Mus musculus molossinus, and exhibits resistance to radiogenic cancers. 8, 18) This model system offers an opportunity to analyze the molecular mechanisms of radiation carcinogenesis.
Two hypotheses have been proposed regarding the mechanism of radiation carcinogenesis. [19] [20] [21] [22] Radiation may lead directly to oncogenic mutations as a result of misrepair and misreplication of DNA damage, and all progeny of the mutant cell would carry the same mutation and generate the malignant clone. It is possible therefore that allelic losses found in the skin tumors, including loss of the wild-type p53 allele, were initiated directly by radiation-induced damage. An alternative is the indirect mechanism, in which radiation initially induces genomic instability that is transmitted through subsequent cell divisions. Radiation is known to induce delayed mutation and such a process increases the probability of later occurrence of transforming mutations. In this scenario, the allelic losses are the secondary result of some as yet unidentified genomic alteration induced by ionizing radiation. The data obtained in this study cannot determine which hypothesis is more probable. On the other hand, genomic instability is a well-established feature of cells with mutations in the p53 gene. p53 is an archetypal regulator of cell-cycle checkpoints and apoptosis, and responds to DNA damage induced by genotoxic agents such as γ-rays. 2, 3, 6, 23, 24) Hence, the frequency of allelic losses or genomic instability in tumors may well be affected by the loss of p53.
